OneSource Specialty Pharma received a USFDA inspection VAI status for its Bengaluru sterile injectables unit on 30 October. The report follows an inspection of the company’s Sterile Product Division by the US drug regulator between 22 and 30 June 2026. An Establishment Inspection Report, or EIR, is the formal write-up the regulator issues once an inspection ends.